Microfluidic Biochip for Rapid Hemoglobin Disorder Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing hemoglobin disorders like sickle cell disease are costly, time-consuming, and inaccessible in low-income countries, leading to high mortality rates due to the lack of early and equitable diagnosis.
Innovation Solution
A biochip system that includes an electrophoresis biochip with a housing, buffer ports, a sample loading port, and electrodes, using cellulose acetate paper saturated with an alkaline buffer solution, and an imaging system for visualizing and quantifying hemoglobin variants, allowing for rapid and accurate diagnosis of hemoglobin disorders using a small blood sample.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional hemoglobin screening methods are used, then diagnostic accuracy is maintained, but the cost and time required increase significantly, making them inaccessible in low-income countries
Solution Approach 1:
The patent employs disposable microfluidic chips with integrated electrophoresis channels and detection zones that are inexpensive to manufacture and use. These single-use chips eliminate the need for expensive, reusable equipment while maintaining diagnostic accuracy, making the system cost-effective for low-income settings.
Solution Approach 2:
The invention replaces complex mechanical laboratory equipment with a simplified microfluidic-electrophoresis system that uses electric fields for separation and optical detection for analysis. This substitution reduces mechanical complexity and maintenance requirements while accelerating the diagnosis process.
2Productivity
If traditional hemoglobin screening methods are used, then comprehensive analysis is achieved, but the time required extends to 2-6 weeks, preventing timely intervention
Solution Approach 1:
The microfluidic chip is pre-designed with optimized electrophoresis channels, buffer reservoirs, and detection zones that are prepared in advance. The alkaline buffer solution is pre-loaded into the chip, eliminating preparation time and enabling immediate analysis upon sample introduction, thus achieving rapid diagnosis without compromising precision.
Solution Approach 2:
The invention changes the operating parameters by using high-voltage electrophoresis (rapid separation) combined with sensitive optical detection methods. This parameter optimization reduces analysis time from weeks to minutes while maintaining or improving detection accuracy for hemoglobin variants.
3Ease of operation
If skilled personnel are required to operate traditional tests, then diagnostic reliability is maintained, but the complexity of operation increases, limiting accessibility
Solution Approach 1:
The microfluidic chip is designed as a self-contained system that performs buffer loading, sample processing, electrophoresis separation, and result detection automatically. The integrated design eliminates the need for skilled operators to perform complex manual procedures, making the system easy to operate while maintaining reliable diagnostic results through standardized protocols.
4Quantity of substance
If extensive blood samples are used for analysis, then comprehensive hemoglobin profile is obtained, but the sample volume requirement increases, complicating point-of-care testing
Solution Approach 1:
The invention segments the blood sample analysis into distinct microfluidic zones within the chip, including separation channels, detection regions, and waste collection areas. This segmentation allows efficient use of minimal sample volume (microliter scale) while maintaining comprehensive hemoglobin profile analysis through spatially resolved detection of different variants.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, cost-effective, and accurate diagnosis of hemoglobin disorders, including sickle cell disease, with results obtainable in minutes, suitable for point-of-care settings, thereby reducing mortality rates by facilitating early intervention.
Implementation Method 1
The first electrode and the second electrode can generate an electric field across the cellulose acetate paper effective to promote migration of hemoglobin variants in the blood sample along the cellulose acetate paper
Data Source
Figure 1A~1E
Figure 2A~2B
Figure 3A~3B
AI summary
A biochip compatible with very small blood sample volumes is used for detecting for detecting hemoglobin disorders and monitoring disorders associated with aberrant blood cell deformability and adhesion, including disease severity, upcoming pain crisis, treatment response, and treatment effectiveness in a clinically meaningful way.